Veedol Corporation Limited has announced the resignation of Shri Brajesh Kumar Srivastava from its Board of Directors, effective January 16, 2026. The company disclosed this development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignation Details

Shri Brajesh Kumar Srivastava, who served as a Non-Executive and Non-Independent Director with DIN 09835338, submitted his resignation effective from the close of business on January 16, 2026. The resignation follows his departure from the Ministry of Heavy Industries.

Regulatory Compliance

The company has fulfilled its disclosure obligations by notifying both the National Stock Exchange of India Limited and BSE Limited about the directorial change. The resignation was communicated through proper channels with all necessary documentation, including the prescribed format under SEBI regulations.

Formal Board Process

According to the company's disclosure, the resignation will be formally noted by the Board of Directors in their upcoming board meeting. This follows standard corporate governance procedures for recording directorial changes.

Director's Statement

In his resignation letter to the Board, Srivastava expressed gratitude for the opportunity to serve as a Director and thanked his board colleagues for their support. He extended his best wishes to the company for continued success in its future endeavors.

The disclosure was signed by Abhijit Tikekar, Company Secretary & Head Legal, ensuring proper documentation and regulatory compliance for this board-level change.

Veedol Corporation Limited has officially completed the closure of its wholly owned subsidiary Veedol Deutschland GmbH in Germany, with the liquidation now formally entered in the German commercial register. The company announced this development on January 15, 2026, marking the completion of a closure process that was initially disclosed on May 18, 2024.

Closure Details and Timeline

The closure represents the final step in the liquidation process of the German subsidiary. Veedol Corporation has emphasized that this closure will not have any impact on the company's business operations, suggesting the subsidiary had minimal operational significance to the parent company's core activities.

Financial Impact Assessment

The subsidiary's financial contribution to Veedol Corporation was negligible, as detailed in the regulatory disclosure. During the last financial year, Veedol Deutschland GmbH contributed nil amounts across all key financial metrics.

Regulatory Compliance

Veedol Corporation has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive details as required pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

The transaction does not constitute a sale or disposal, as it represents a closure of operations rather than a transfer to third parties. Consequently, considerations related to sale agreements, buyer details, related party transactions, and arms-length pricing are not applicable to this closure.

Corporate Structure Simplification

The closure of Veedol Deutschland GmbH represents a streamlining of Veedol Corporation's international subsidiary structure. Given the subsidiary's nil contribution to financial performance, this closure appears to be part of operational efficiency measures without affecting the company's core business activities or revenue streams.